Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study

被引:0
作者
Berbel L. M. Ykema
Tanya M. Bisseling
Manon C. W. Spaander
Leon M. G. Moons
Dorien van der Biessen-van Beek
Lisette Saveur
Martijn Kerst
Sasja F. Mulder
Ronald de Wit
Danielle Zweers
Gerrit A. Meijer
Jos H. Beijnen
Iris Lansdorp-Vogelaar
Flora E. van Leeuwen
Petur Snaebjornsson
Monique E. van Leerdam
机构
[1] Netherlands Cancer Institute,Department of Gastroenterology and Hepatology
[2] Radboud University Medical Center,Department of Gastroenterology and Hepatology
[3] Erasmus University Medical Center,Department of Gastroenterology and Hepatology
[4] University Medical Center Utrecht,Department of Gastroenterology and Hepatology
[5] Netherlands Cancer Institute,Department of Medical Oncology
[6] Radboud University Medical Center,Department of Medical Oncology
[7] Erasmus University Medical Center,Department of Medical Oncology
[8] University Medical Center Utrecht,Department of Medical Oncology
[9] Netherlands Cancer Institute,Department of Pathology
[10] Netherlands Cancer Institute,Department of Pharmacy and Pharmacology
[11] Erasmus University Medical Center,Department of Public Health
[12] Netherlands Cancer Institute,Department of Epidemiology
[13] Leiden University Medical Center,Department of Gastroenterology and Hepatology
来源
BMC Gastroenterology | / 21卷
关键词
Colorectal cancer; Colorectal neoplasia; Colonoscopy; Surveillance; Testicular cancer; Platinum-based chemotherapy; Surveillance; Carcinogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 261 条
[1]  
Morton LM(2014)Current knowledge and future research directions in treatment-related second primary malignancies EJC Suppl 12 5-17
[2]  
Swerdlow AJ(2002)Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. 1997 J Urol 167 928-932
[3]  
Schaapveld M(2007)Mortality and incidence of second cancers following treatment for testicular cancer Br J Cancer 96 529-533
[4]  
Ramadan S(2007)Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data Lancet Oncol 8 784-796
[5]  
Hodgson DC(2016)Cancer treatment and survivorship statistics, 2016 CA Cancer J Clin 66 271-289
[6]  
Radford J(2004)Increased mortality rates in young and middle-aged patients with malignant germ cell tumours Br J Cancer 90 607-612
[7]  
Einhorn LH(2018)Risk of solid cancer after treatment of testicular germ cell cancer in the platinum era J Clin Oncol 36 2504-2513
[8]  
Donohue J(2012)Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study Ann Intern Med 156 757-766
[9]  
Robinson D(1990)Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy Br J Cancer 61 639-643
[10]  
Moller H(2014)Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma Br J Cancer 110 256-263